Henry Schein (HSIC.US) Price Target and Rating 2026/2027

88,58
-1,13%
Price history for Henry Schein (HSIC.US) – stock price at 88.58 $, August 2026
Henry Schein stock price – price development 2026. Updated Aug 6, 2026.
Share this analysis:

Henry Schein Price Target 2026: Analysts See 1% Upside

The average price target for Henry Schein is $89.63. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 1,19% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.

Is Henry Schein overvalued or undervalued?

Henry Schein is currently fairly valued with a gap of 1.2% relative to the price target.


The current price is $88.58, which places Henry Schein in the fairly valued category. The stock is considered undervalued when the price is below $80.67, and overvalued when the price exceeds $98.59.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For Henry Schein, the fair value range lies between $80.67 and $98.59.


See the full price target analysis for Henry Schein →

Analyst Ratings for Henry Schein stock in 2026: Buy

16 analysts cover Henry Schein. Analysts are mostly neutral — 50% recommend Hold. The average price target is $89.63, which gives an upside of 1.2% from the current price.

Consensus: Buy (3.50/5)
Strong Buy
3 (18.8%)
Buy
4 (25%)
Hold
8 (50%)
Strong Sell
1 (6.3%)
Strong Sell Sell Hold Buy Strong Buy
3.50 out of 5 based on 16 analysts

About Henry Schein – Medicinsalg

Henry Schein, Inc. driver en global forretning, hvor de leverer produkter og services til sundhedssektoren. De tjener primært penge på to områder: distribution af varer og teknologiske løsninger. Virksomheden sælger alt fra tandlægeudstyr som røgnsapparater og bedøvelsesmidler til medicinske produkter som vacciner og diagnostiske tests. De distribuerer også personligt beskyttelsesudstyr, hvilket er en stor del af deres forretning. Henry Schein servicerer tandlæger, lægepraksisser og institutionelle klinikker over hele verden. Deres teknologi-division leverer software og værdiskabende services, der hjælper klinikker med at drive deres forretning mere effektivt. Henry Schein blev grundlagt i 1932 og har i dag over 22.000 ansatte. Read more about the company

Key Figures for Henry Schein

$ 10,2B Market cap
$ 13,4B Revenue
Medicinsalg Industry
26.92 P/E
0.76 P/S
2.99 P/B
USA Listed on exchange
Sundhed Sector

What kind of stock is Henry Schein?

Momentum stock

Henry Schein is classified as a momentum stock with a momentum score in the top 14% of all stocks. The price has risen 0.0% over the long term.

Score Overview for Henry Schein

💰 Value Score 64/100 (High)
⭐ Quality Score 52/100 (Neutral)
🚀 Momentum Score 86/100 (Very High)
📊 Total Score 67/100

⚠️ 1 red flag identified

Our analysis has identified 1 potential risk factor in Henry Schein that investors should be aware of.

⚠️ High debt: The debt-to-equity ratio is 159% – the company carries considerably more debt than equity, which raises the financial risk.

📈 Valuation

Henry Schein trades at a P/E ratio of 26.9, which is above the market average. The forward P/E is 16.0 (40% lower), which suggests the market expects rising earnings. The P/S ratio is 0.8 (low — potentially undervalued relative to revenue). The P/B ratio is 3.0. The PEG ratio is 1.84.

💵 Profitability & Growth

Henry Schein has a profit margin of 3.0% (moderate) and an operating margin of 5.9%. Return on equity (ROE) is 8.8%. Return on assets (ROA) is 4.4%. The latest quarterly earnings grew 4.5% year over year.

🏦 Financial Health

The Piotroski score is 7 out of 9 — good financial health. Altman Z2 is 2.47 (middle zone — moderate). The debt-to-equity ratio (D/E) is 158.6% — moderate debt.

🚀 Momentum & Short Interest

Short interest is 6.92% — elevated, some investors are betting on a decline.

Insider Trading in Henry Schein 2026: The Signal Is clearly positive

In 2026, insiders at Henry Schein have made 20 transactions – split into 1 purchases and 19 sales. On a net basis, insiders took 9,302,272 $ out of the stock. Active insiders include DANIEL WILLIAM K, Thomas C Popeck, Popeck Thomas C and others. In the short term (last 3 months), the insider signal is clearly positive.

Short-Term Signal (3 months): Clearly positive

Insiders have exclusively bought shares over the last 3 months. This is a strong signal of confidence in the company in the short term.

Over the last 3 months: 1 purchases and 0 sales. A net 691,900 $ into the stock.

Long-Term Signal (all transactions): Mostly negative

Insiders have sold considerably more than they have bought. At large companies this can be due to planned sales (10b5-1 plans) and is not necessarily a negative signal.

Across the last 20 transactions: 1 purchases and 19 sales. A net 9,302,272 $ out of the stock.

Latest purchase: DANIEL WILLIAM K bought 10,000 shares at 69 $ each on 2026-05-11. The stock has since risen 29.5%.

Latest sale: Thomas C Popeck sold 1,355 shares at 73 $ each on 2026-03-19.

Who is buying: DANIEL WILLIAM K.

Who is selling: Thomas C Popeck, Popeck Thomas C, South Ronald N., Sheehy Christine Zayac, MLOTEK MARK E and others.

Latest Insider Trades in Henry Schein (2026)

The table shows the last 20 reported insider transactions in Henry Schein. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share ($) Total amount ($)
2026-05-11 DANIEL WILLIAM K Buy 10,000 69 691,900
2026-03-19 Thomas C Popeck Sell 1,355 73 98,630
2026-03-19 Popeck Thomas C Sell 1,355 73 98,630
2026-03-16 South Ronald N. Sell 5,216 75 389,166
2026-03-16 Sheehy Christine Zayac Sell 463 75 34,544
2026-03-16 Popeck Thomas C Sell 587 75 43,796
2026-03-16 MLOTEK MARK E Sell 5,928 75 442,288
2026-03-16 Ettinger Michael S Sell 1,300 75 96,993
2026-03-16 BERGMAN STANLEY M Sell 400 75 29,844
2026-03-16 Albertini Andrea Sell 1,401 75 104,529

Who is buying and selling Henry Schein shares in 2026?

The following insiders have bought shares in Henry Schein: DANIEL WILLIAM K. In total, 691,900 $ was bought across 1 transactions. The following insiders have sold shares: Thomas C Popeck, Popeck Thomas C, South Ronald N., Sheehy Christine Zayac, MLOTEK MARK E and others. In total, 9,994,172 $ was sold across 19 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

Henry Schein Short Selling 2026: 6.9% Sold Short

High short interest: 6.9% of the free float
Short % of free float
6.9%
Assessment
High short interest
Short squeeze risk
Moderate
Data source
SEC
Updated daily
The stock has a high share of short selling. Between 5-10% of the freely traded shares are sold short, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze.

What does this mean for you as an investor?
A short interest of 6.9% means that 6.9% of the freely traded shares in Henry Schein have been borrowed and sold by investors betting on falling prices.

Data is updated daily based on official filings with the SEC.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
6.9%

When Does Henry Schein Report Earnings?

The next earnings date for Henry Schein is not yet available. Check the company's investor calendar for more information.



Technical Analysis of Henry Schein 2026 – Signal: Strong Buy

Overall Technical Signal: Strong Buy

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated August 6, 2026.

Technical analysis of Henry Schein (HSIC.US) – RSI 68, MACD positive (bullish), daily candlestick chart August 2026
Henry Schein technical analysis – candlestick chart with RSI and MACD. Updated Aug 6, 2026.

Trend Analysis of Henry Schein, Inc

Henry Schein, Inc is in a short-term uptrend. The price of $89.59 is 4.0% above the 20-day average ($86.17). Medium term, the picture is positive: the price is 8.4% above the 50-day average ($82.68). Long term, the stock is 16.9% above the 200-day average ($76.66), which confirms a long-term uptrend.

Golden Cross: The 50-day average (82.68) is above the 200-day average (76.66), which is a classic bullish signal for Henry Schein, Inc.

Is Henry Schein, Inc overbought or oversold?

Henry Schein, Inc has an RSI of 67.9. The stock shows positive momentum in the upper part of the neutral zone. Combined with the positive trend, this supports the bullish picture.

MACD Analysis for Henry Schein, Inc

Daily MACD: MACD is positive (1.328), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is above the signal line (1.228) by 0.100, which confirms rising momentum in the uptrend.

Weekly MACD: MACD5 is positive (3.168), which indicates a broader bullish long-term trend. MACD5 is above the signal line (2.074) by 1.094, which confirms rising long-term momentum.

Overall MACD assessment: Both the daily and weekly MACD are positive and above their signal lines. Trend and momentum confirm each other across time horizons – the strongest bullish signal.

Risk Profile for Henry Schein, Inc

Henry Schein, Inc has an annual standard deviation of 26.1%, which classifies the stock as moderately low risk. There is some volatility, but the price is relatively stable.

Overall Technical Conclusion for Henry Schein, Inc

Trend: Positive. The price trades above SMA50 and SMA200.

MACD trend (zero line): Daily bullish (1.328). Weekly bullish (3.168).

MACD momentum (signal): Daily rising. Weekly rising.

RSI: 67.9 – neutral.

Technical signal: Strong Buy

The price is in an uptrend (above SMA50/SMA200) and MACD is positive on both a daily and weekly basis. Trend and MACD trend confirm each other – the strongest technical buy signal.

Frequently Asked Questions About Henry Schein stock in 2026

Should you buy Henry Schein stock now?
Yes, the technical signal for Henry Schein is currently BUY. Henry Schein trades at $88.58 as of 8/6/2026. The overall technical signal is: Strong Buy. The technical analysis shows the following: MACD is positive (bullish trend) at 1.328 with rising momentum (signal: 1.228); RSI is at 67.9 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $89.63 points to 1.2% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Henry Schein stock?
The average analyst price target for Henry Schein is $89.63. The current price is $88.58, which gives an upside of 1.2%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $80.67 and $98.59.
Is Henry Schein a dividend stock?
No, Henry Schein does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Henry Schein stock?
Henry Schein is rated as a stock with moderately low risk. the annual standard deviation is 26.1%, which classifies the stock as moderately low risk.
Is Henry Schein overvalued?
Henry Schein is considered fairly valued – the price is close to the analyst price target. Henry Schein has the following valuation ratios: a P/E ratio of 26.9 (moderately to highly valued), a P/S ratio of 0.8, a P/B ratio of 3.0. The stock trades close to the analyst price target and is considered fairly valued.
Is Henry Schein overbought?
No, Henry Schein is not overbought. RSI is at 67.9 (neutral zone). The technical indicators show: RSI is at 67.9 (upper neutral zone), which shows positive momentum but is not yet overbought. In addition, the price is 2.8% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Henry Schein earnings report?
The date of the next earnings report for Henry Schein has not been published yet. Check the company's investor calendar for updates.
Is Henry Schein shorted?
Yes, Henry Schein is shorted with 6.9% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. Data is updated daily based on official filings with the SEC.
Are insiders buying Henry Schein stock?
Yes, insiders are net buyers of Henry Schein – they are buying more shares than they are selling. Over the last 3 months, insiders have made 1 purchases and 0 sales. On a net basis, 691,900 $ worth of shares were bought. Across the last 20 reported transactions, the split is 1 purchases and 19 sales, with a net 9,302,272 $ sold. Active buyers include DANIEL WILLIAM K. Insider buying is generally seen as a positive signal, because management is putting its own money into the company.
Is Henry Schein a good stock?
Based on our total score, Henry Schein is rated as a good stock with a total score of 67 out of 100. The stock scores above average on value, quality and momentum – it is among the top 33% in our database. The score is made up of Value: 64/100, Quality: 52/100, Momentum: 86/100. In addition: technical signal: Strong Buy. Whether Henry Schein is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Henry Schein stock?
The outlook for Henry Schein based on current data: the average analyst price target is $89.63 (+1.2%); the stock is in an uptrend (above SMA50 and SMA200); the P/E ratio is 26.9 (moderate). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Henry Schein stock rising?
Henry Schein is rising right now. The technical indicators show: the price is 2.8% above the 20-day average; MACD is positive with rising momentum (bullish signal); short interest is 6.9% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Henry Schein go?
The average analyst price target for Henry Schein is $89.63, which corresponds to a potential gain of 1.2% from the current price of $88.58. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Henry Schein fall?
We lack enough history to give a specific floor for Henry Schein. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Henry Schein do?
Henry Schein, Inc. driver en global forretning, hvor de leverer produkter og services til sundhedssektoren. De tjener primært penge på to områder: distribution af varer og teknologiske løsninger. Virksomheden sælger alt fra tandlægeudstyr som røgnsapparater og bedøvelsesmidle... The company belongs to the Sundhed sector, more specifically the Medicinsalg industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Henry Schein as an investment.
Did Henry Schein raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Henry Schein. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Henry Schein making money or losing money?
Yes, Henry Schein is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 3.0% — which is modest. The operating margin (profit before interest and taxes) is 5.9%. At a P/E ratio of 26.9, you currently pay 26.9 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Henry Schein go bankrupt?
The bankruptcy risk of Henry Schein is rated as moderate. Altman Z2 (a model for assessing financial distress) is 2.47 — that places the company in the middle zone. The Piotroski score (financial health 0-9, higher is better) is 7 — which is strong. Debt relative to equity is 159% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Henry Schein have a lot of debt?
Yes, Henry Schein has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 159%. For the sundhed sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.